These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1503357)

  • 21. Cost effectiveness of cervical cancer screening for the elderly.
    Fahs MC; Mandelblatt J; Schechter C; Muller C
    Ann Intern Med; 1992 Sep; 117(6):520-7. PubMed ID: 1503355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for cervical neoplasia.
    Cronjé HS; Niemand I
    S Afr Med J; 1995 Mar; 85(3):184. PubMed ID: 7777979
    [No Abstract]   [Full Text] [Related]  

  • 23. Cervical cytology--cost effective considerations.
    Medley G; Drake M
    Aust Health Rev; 1982 May; 5(2):9-14. PubMed ID: 10309737
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost effectiveness of cervical cancer screening among Chinese women in North America.
    Thompson B; Thompson AL; Chan NL; Hislop GT; Taylor VM
    Asian Pac J Cancer Prev; 2007; 8(2):287-93. PubMed ID: 17696748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Levin CE; Sellors JW
    Cancer; 2002 Apr; 94(8):2312-4; author reply 2314-6. PubMed ID: 12001136
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of cervical cytology.
    McCrory DC; Matchar DB; Bastian L; Datta S; Hasselblad V; Hickey J; Myers E; Nanda K
    Evid Rep Technol Assess (Summ); 1999 Jan; (5):1-6. PubMed ID: 11925972
    [No Abstract]   [Full Text] [Related]  

  • 27. National Cervical Screening Programme.
    BMJ; 1990 Nov; 301(6760):1100. PubMed ID: 2123413
    [No Abstract]   [Full Text] [Related]  

  • 28. Summaries for patients. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States.
    Ann Intern Med; 2009 Oct; 151(8):I36. PubMed ID: 19841439
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cost-benefit analysis of the Program for Early Screening of Cervico-uterine Cancer].
    Hernández-Peña P; Lazcano-Ponce EC; Alonso-de Ruiz P; Cruz-Valdez A; Meneses-González F; Hernández-Avila M
    Salud Publica Mex; 1997; 39(4):379-87. PubMed ID: 9381251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Costs of population cervical cancer screening program in Poland between 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
    Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical carcinoma in Nigeria--a need for early detection.
    Edozien LC; Adewole IF
    Afr J Med Med Sci; 1993 Dec; 22(4):87-92. PubMed ID: 7839937
    [No Abstract]   [Full Text] [Related]  

  • 32. Cervical cancer screening: the time for reappraisal.
    Skrabanek P
    Can J Public Health; 1988; 79(2):86-9. PubMed ID: 3383065
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness of cervical cancer screening: comparison of screening policies.
    van den Akker-van Marle ME; van Ballegooijen M; van Oortmarssen GJ; Boer R; Habbema JD
    J Natl Cancer Inst; 2002 Feb; 94(3):193-204. PubMed ID: 11830609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determining the cost-effectiveness of mass screening for cervical cancer using common analytic models.
    Sato S; Matunaga G; Tsuji I; Yajima A; Sasaki H
    Acta Cytol; 1999; 43(6):1006-14. PubMed ID: 10578971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Care and costs for advanced cervical cancer.
    van Ballegooijen M; Koopmanschap MA; Tjokrowardojo AJ; van Oortmarssen GJ
    Eur J Cancer; 1992; 28A(10):1703-8. PubMed ID: 1389489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global human papillomavirus vaccination: can it be cost-effective?
    Crosbie EJ
    BJOG; 2012 Jan; 119(2):125-8. PubMed ID: 22168760
    [No Abstract]   [Full Text] [Related]  

  • 38. Cervical screening program for Sri Lanka--can we afford it?
    Sirisena J
    Ceylon Med J; 1999 Mar; 44(1):41-5. PubMed ID: 10643099
    [No Abstract]   [Full Text] [Related]  

  • 39. A prospective randomized study of two reminding strategies: telephone versus mail in the screening of cervical cancer in women who did not initially respond.
    Heranney D; Fender M; Velten M; Baldauf JJ
    Acta Cytol; 2011; 55(4):334-40. PubMed ID: 21791902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An economic appraisal of a mobile cervical cytology screening service.
    Bloch B
    S Afr Med J; 1997 Feb; 87(2):231. PubMed ID: 9180819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.